(Q39372010)

English

EGF promotes neuroendocrine-like differentiation of prostate cancer cells in the presence of LY294002 through increased ErbB2 expression independent of the phosphatidylinositol 3-kinase-AKT pathway

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

EGF promotes neuroendocrine-like differentiation of prostate cancer cells in the presence of LY294002 through increased ErbB2 expression independent of the phosphatidylinositol 3-kinase-AKT pathway (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

prostate cancer

1 reference

based on heuristic

inferred from title

Ariel E Cariaga-Martínez

object named as

Ariel E Cariaga-Martinez

2

0 references

Javier C. Angulo

object named as

Javier Angulo

7

0 references

author name string

M Alicia Cortés

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

María V T Lobo

3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Rosa M Martín Orozco

4

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Omar Motiño

5

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

F Javier Rodríguez-Ubreva

6

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Pilar López-Ruiz

8

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Begoña Colás

9

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

language of work or name

0 references

publication date

29 March 2012

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

1169-1177

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

New strategies in metastatic prostate cancer: targeting the androgen receptor signaling pathway

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS139

21 January 2018

EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS139

21 January 2018

Steroid hormones, polypeptide growth factors, hormone refractory prostate cancer, and the neuroendocrine phenotype

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS139

21 January 2018

Neuroendocrine differentiation in human prostate cancer. Morphogenesis, proliferation and androgen receptor status

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS139

21 January 2018

Neuroendocrine differentiation in prostate cancer: implications for new treatment modalities

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS139

21 January 2018

Influence of neuroendocrine tumor cells on proliferation in prostatic carcinoma.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS139

21 January 2018

Phosphorylation of both EGFR and ErbB2 is a reliable predictor of prostate cancer cell proliferation in response to EGF.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS139

21 January 2018

ErbB receptors: possible therapeutic targets in prostate cancer?

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS139

21 January 2018

The ErbB signaling network: receptor heterodimerization in development and cancer

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS139

21 January 2018

Untangling the ErbB signalling network

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS139

21 January 2018

ERBB receptors and cancer: the complexity of targeted inhibitors

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS139

21 January 2018

ErbB receptors: from oncogenes to targeted cancer therapies

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS139

21 January 2018

Low level HER2 overexpression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancer

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS139

21 January 2018

A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS139

21 January 2018

HER2/neu kinase-dependent modulation of androgen receptor function through effects on DNA binding and stability

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS139

21 January 2018

From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS139

21 January 2018

EGF prevents the neuroendocrine differentiation of LNCaP cells induced by serum deprivation: the modulator role of PI3K/Akt

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS139

21 January 2018

ErbB1 and prostate cancer: ErbB1 activity is essential for androgen-induced proliferation and protection from the apoptotic effects of LY294002.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS139

21 January 2018

A standard curve based method for relative real time PCR data processing

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS139

21 January 2018

Multipathways for transdifferentiation of human prostate cancer cells into neuroendocrine-like phenotype

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS139

21 January 2018

LY294002 and LY303511 sensitize tumor cells to drug-induced apoptosis via intracellular hydrogen peroxide production independent of the phosphoinositide 3-kinase-Akt pathway

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS139

21 January 2018

Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS139

21 January 2018

Exploring the specificity of the PI3K family inhibitor LY294002.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS139

21 January 2018

LY303511 (2-piperazinyl-8-phenyl-4H-1-benzopyran-4-one) acts via phosphatidylinositol 3-kinase-independent pathways to inhibit cell proliferation via mammalian target of rapamycin (mTOR)- and non-mTOR-dependent mechanisms

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS139

21 January 2018

NF-kappaB-mediated HER2 overexpression in radiation-adaptive resistance

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS139

21 January 2018

Enhancement of cytokine-mediated NF-kappaB activation by phosphatidylinositol 3-kinase inhibitors in monocytic cells

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS139

21 January 2018

The phosphatidylinositol 3-kinase inhibitor LY294002 binds the estrogen receptor and inhibits 17beta-estradiol-induced transcriptional activity of an estrogen sensitive reporter gene

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS139

21 January 2018

Estrogen receptor beta in the prostate

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS139

21 January 2018

Different mechanisms are implicated in ERBB2 gene overexpression in breast and in other cancers

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS139

21 January 2018

Her-2-neu expression and progression toward androgen independence in human prostate cancer.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS139

21 January 2018

Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS139

21 January 2018

Identifiers

10.1093/CARCIN/BGS139

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39372010&oldid=1966858275"